Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 26 is a pseudogene, meaning it is a non-functional segment of DNA that resembles the functional mitochondrial gene MT-ND5, which codes for NADH-ubiquinone oxidoreductase chain 5, a core subunit of mitochondrial complex I. Pseudogenes do not produce functional proteins and are not considered therapeutic targets or involved in known biological functions or disease processes. There are no known drug interactions, disease associations, biomarker roles, or safety concerns related to MTND5P26. The presence of "pseudogene" in the name and its classification as a pseudogene means it does not yield a functional gene product or serve as a receptor, enzyme, transporter, or other pharmacologically relevant target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 26 (MTND5P26).